Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Obst, M.
Right arrow Articles by Luft, F. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Obst, M.
Right arrow Articles by Luft, F. C.
J Am Soc Nephrol 14:303-310, 2003
© 2003 American Society of Nephrology

Pressure Natriuresis in AT2 Receptor–Deficient Mice with L-NAME Hypertension

Michael Obst*, Volkmar Gross*, Jürgen Janke{dagger}, Maren Wellner{dagger}, Wolfgang Schneider{dagger} and Friedrich C. Luft{dagger}

*Max-Delbrück-Center (MDC) for Molecular Medicine, HELIOS-Klinikum-Berlin, Franz Volhard Clinic, Medical Faculty of the Charité, {dagger}Humboldt University, Berlin, Germany.

Correspondence to Dr. Friedrich C. Luft, Franz Volhard Clinic, Wiltbergstrasse 50 13125 Berlin, Germany. Phone: 49-30-9417-2202; Fax: 49-30-9417-2206;

ABSTRACT. AT2 receptor-disrupted (AT2 -/-) mice provide a unique opportunity to investigate the cardiovascular and BP-related effects of NO depletion. This study compared the pressure-diuresis-natriuresis relationship in (AT2 -/-) and wild-type (AT2 +/+) mice after treating the animals with L-NAME (130 mg/kg body wt per day) for 1 wk. L-NAME increased mean arterial pressure (MAP) more in AT2 -/- than in AT2 +/+ mice (118 ± 2 versus 108 ± 4 mmHg). This difference occurred even though L-NAME–treated AT2 +/+ mice had a greater sodium excretion than AT2 -/- mice (10.9 ± 0.5 versus 8.0 ± 1.0 µmol/h). The pressure-natriuresis relationship in conscious AT2 -/- mice was shifted rightward compared with controls. RBF was decreased in AT2 -/- compared with AT2 +/+ mice. L-NAME decreased RBF in these mice further from 4.08 ± 0.43 to 2.79 ± 0.15 ml/min per g of kidney wt. GFR was not significantly different between AT2 +/+ and AT2 -/- mice (1.09 ± 0.08 versus 1.21 ± 0.09 ml/min per g of kidney wt). L-NAME reduced GFR in AT2 -/- to 0.87 ± 0.07 ml/min per g of kidney wt. Fractional sodium (FENa) and water (FEH2O) curves were shifted more strongly to the right by L-NAME in AT2 -/- mice than in AT2 +/+ mice. AT1 receptor blocker treatment lowered BP in both L-NAME–treated strains to basal values. It is concluded that the AT1 receptor plays a key role in the impaired renal sodium and water excretion induced by NO synthesis blockade. Changes in RBF, GFR, and tubular sodium and water reabsorption are involved and may be also responsible for the greater BP increase in L-NAME–treated AT2 -/- mice. E-mail: luft@fvk-berlin.de




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Z. Haque and D. S. A. Majid
Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase
Am J Physiol Renal Physiol, September 1, 2008; 295(3): F758 - F764.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. M. Fitzgerald, B. K. Kemp-Harper, H. C. Parkington, G. A. Head, and R. G. Evans
Endothelial dysfunction and arterial pressure regulation during early diabetes in mice: roles for nitric oxide and endothelium-derived hyperpolarizing factor
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R707 - R713.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Shariat-Madar, F. Mahdi, M. Warnock, J. W. Homeister, S. Srikanth, Y. Krijanovski, L. J. Murphey, A. A. Jaffa, and A. H. Schmaier
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin
Blood, July 1, 2006; 108(1): 192 - 199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Obst, J. Tank, R. Plehm, K. J. Blumer, A. Diedrich, J. Jordan, F. C. Luft, and V. Gross
NO-dependent blood pressure regulation in RGS2-deficient mice
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1012 - R1019.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. M. Bove, Z. Yang, W. D. Gilson, F. H. Epstein, B. A. French, S. S. Berr, S. P. Bishop, H. Matsubara, R. M. Carey, and C. M. Kramer
Nitric Oxide Mediates Benefits of Angiotensin II Type 2 Receptor Overexpression During Post-Infarct Remodeling
Hypertension, March 1, 2004; 43(3): 680 - 685.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-S. Zhou, A. G. Adam, E. A. Jaimes, and L. Raij
In Salt-Sensitive Hypertension, Increased Superoxide Production Is Linked to Functional Upregulation of Angiotensin II
Hypertension, November 1, 2003; 42(5): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. M. Carey and H. M. Siragy
Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
Endocr. Rev., June 1, 2003; 24(3): 261 - 271.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP